MyJournals Home  

RSS FeedsCancer immunoediting and resistance to T cell-based immunotherapy (Nature Clinical Practice Oncology)

 
 

8 december 2018 18:00:24

 
Cancer immunoediting and resistance to T cell-based immunotherapy (Nature Clinical Practice Oncology)
 






Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
14 viewsCategory: Oncology
 
BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy)
Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer (Nature Clinical Practice Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2018 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn